Through Peer2Peer, we continuously create insightful video content with leading surgeons on the topics that are important to you. Watch past webinars, engaging video interviews with thought leaders in cataract and refractive surgery, interesting case studies, as well as clinical presentations from in-person events and congresses. If you would like to feature in a Peer2Peer video, please speak to your Rayner representative or contact omidriahcp@rayner.com
OMIDRIA is making waves in refractive cataract surgery, and Dr. Michael Endl, a Buffalo, New York ophthalmologist and keen OMIDRIA user, joined us to chat about it. In this video, Dr. Endl talks about the impact of Rayner’s OMIDRIA on his practice and drop burden, the surgical experience for doctors,…
Hear Dr. Donnenfeld discuss the role of OMIDRIA in reducing inflammation during cataract surgery and how it improves postoperative care with fewer complications. In some cases, the use of intracameral OMIDRIA has allowed him to eliminate the need for non-steroidal and steroid medications in the postoperative regimen, resulting in a…
Dr. Sturbaum highlights the numerous benefits of OMIDRIA, including reduced surgical times in patients with floppy iris syndrome, decreased use of postoperative drops, minimized postoperative CME, and a significant time and cost savings by reducing the need for pupil expanding devices.
Listen to Dr. Stonecipher highlight the intraoperative and postoperative advantages of OMIDRIA, explaining how he believes it optimizes outcomes and enhances patient experiences.
Dr. Kontos shares his perspective that having OMIDRIA on board for cataract surgery simplifies a surgeon’s life by maintaining pupil dilation and reducing the likelihood of patients experiencing postoperative discomfort or pain, thus contributing to creating a positive surgical experience for his patients.
Dr. Katsev emphasizes that OMIDRIA plays a crucial role in maintaining pupil dilation and reducing inflammation, which greatly impacts surgical outcome quality and allows him to achieve optimal results.
Dr. Bucci emphasizes the significance of OMIDRIA in cataract surgery by highlighting its effect on maintaining pupil dilation, and asking "why not" reduce inflammation and prevent cataract surgery complications.
Dr. Olsen acknowledges the complexities of small pupil cases in cataract surgery. Since adopting OMIDRIA in all procedures, he has witnessed a decrease in such cases. Patient eyes remain calm postoperatively, and the streamlined procedures have allowed him to save time on each case.
Dr. Donaldson highlights the impact OMIDRIA has on the safety and efficiency of her cataract surgery procedures, emphasizing that OMIDRIA provides her the opportunity to reduce the burden of postoperative eye drops, ultimately leading to an improved patient experience.
Dr. Nikpoor highlights how using OMIDRIA simplifies cataract surgery by eliminating the need for additional intraoperative dilation. With OMIDRIA she has confidence that the pupil size will remain stable, resulting in improved patient outcomes with reduced perioperative and postoperative pain and minimized ocular inflammation.
Dr. McCabe emphasizes the advantages of OMIDRIA on patient outcomes. One significant benefit highlighted is the reassurance it offers by preventing unexpected events such as pupil constriction and iris movement during surgery.
Listen to Dr. Greenwood as he explains his choice to use OMIDRIA in nearly all his cataract surgery cases. He believes that OMIDRIA provides the predictability of a more efficient and safer surgical experience while also offering the postoperative benefits of a reduced drop regimen.
Dr. Foster shares his belief that OMIDRIA utilization not only enables him to deliver high quality surgeries while minimizing the risk of complications, but it also significantly reduces the likelihood of patients experiencing discomfort both during the surgery itself and in the immediate postoperative period. This profound advantage, in his…
Dr. Jackson shares his experience with using OMIDRIA for the past eight years. He discusses how OMIDRIA continues to simplify his life as a surgeon by maintaining pupil dilation, ensuring a quieter postoperative eye, and signficantly reducing the risk of developing CME.
Listen to Dr. Singh as he shares valuable insights on the effectiveness of OMIDRIA in his cataract surgeries, including its impact on complex cases and simplification of his postoperative drop regimen.
Listen to KOLs from across the country share their experiences with OMIDRIA, including providing advice to surgeons who have not used it previously. They invite surgeons to gain their own clinical experience and ask "why not" add a medication that has been proven to improve the surgeon, clinic and patient…
Gain valuable insights from Dr. Wagle and ASC Administrator Heather Higendorf-Cooley as they share their comprehensive perspectives on OMIDRIA, spanning clincal expertise and administrative considerations.
Drs. McCabe and Shamie discuss pupillary miosis and its implications for surgeons and patients alike. Hear how utilizing OMIDRIA has made cataract surgery more predictable for them.
Discover the benefits of OMIDRIA in cataract surgery through insights from Drs. McCabe and Shamie. Gain valuable knowledge on the reduced occurrence of complications like CME and iritis, and how decreased inflammation leads to improved patient comfort and a positive postoperative experience.
Drs. McCabe and Shamie invite surgeons to accept the OMIDRIA for cataract surgery challenge. They welcome surgeons to evaluate OMIDRIA's impact on crucial factors such as pupil size, iris stability, and patient comfort.
Dr. Metzinger shares how OMIDRIA has impacted surgeons, nurses and scrub techs, due to their simplified intra-operative cataract surgery regimen. Clinically, she speaks to how patients have an improved experience, including less pain/ foreign body sensation and how often even more complicated patients' post operative edema and inflammation is resolved.
Listen to Dr. Metzinger highlight how OMIDRIA has reduced cataract surgery complications in her VA population, improving clinic efficiency, reducing medication burden and significantly reducing both her and her resident's stress levels.
Discover how Dr. Metzinger has been able to reduce intra and post operative steroids since adding OMIDRIA to her cataract surgery regimen. She shares how OMIDRIA delivers a safe, consistent cataract surgery experience that can improve surgeon, clinic and patient experience.
Listen to Drs Wiley and Hura discuss why they started using OMIDRIA and how implementing it has led to an improved surgical experience for patients, surgeons, and staff.
Drs Wiley and Hura share how OMIDRIA contributes to the art of refractive cataract surgery
Expanding the focus beyond the immediate intraoperative benefits of OMIDRIA
Interoperative miosis in a man with no history of α-blocker use
Patients with history of α-blocker usage: a side by side OMIDRIA/No OMIDRIA
Contralateral eye scope view of patient eyes with +2D hyperopia on tamsulosin
Learn why Dr. Visco uses OMIDRIA at her ASC to deliver a better experience to surgical patients.
Hear Dr. Walter share the benefits of OMIDRIA in both patient chair time and improved outcomes.
Listen to Dr. Silverstein discuss how maintaining pupil size during cataract surgery plays a key role in achieving a positive surgical experience and positive patient outcomes.
Learn about real world evidence studies that show lower rates of post-operative CME and why it makes sense to have OMIDRIA on board
See why Dr. Walter describes OMIDRIA as a great red-zone defense.
Dr. Silverstein discusses how OMIDRIA significantly reduced all 3 facets of IFIS in this real world study among male patients with a history of tamsulosin usage.
OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.
OMIDRIA must be added to irrigating solution prior to intraocular use.
OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.
Systemic exposure to phenylephrine may cause elevations in blood pressure.
Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at ≥ 2% are eye irritation, posterior capsule opacification, increased intraocular pressure, and anterior chamber inflammation.
Please see the Full Prescribing Information for OMIDRIA.
You are encouraged to report Suspected Adverse Reactions to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This site is intended for US Physician educational purposes only, using scientific exchange around the OMIDRIA experience.
Rayner, the Rayner logo, OMIDRIA, the OMIDRIA logo, and OMIDRIAssure are proprietary marks of Rayner. ©2022 Rayner Group, all rights reserved. US-OM-2200071 12/22
